PRECIGEN, INC. Equity Method Investments
PRECIGEN, INC. (PGEN) had Equity Method Investments of $0 as of 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:EquityMethodInvestments · last filed 2021-03-01
- 2020-12-31: Equity Method Investments $0.00.
- 2020-09-30: Equity Method Investments $337.00K.
- 2020-06-30: Equity Method Investments $859.00K.
- 2020-03-31: Equity Method Investments $1.11M.
| Period end | Equity Method Investments | Equity Method Investments as first filed |
|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-01 | |
| 2020-09-30 | $337.00K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $859.00K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $1.11M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $1.46M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $17.49M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $18.09M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $17.63M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $2.14M 10-K · filed 2020-03-02 | $18.86M 10-K · filed 2019-03-01 |
| 2018-09-30 | $17.94M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $20.39M 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $21.41M 10-Q/A · filed 2018-08-13 | |
| 2017-12-31 | $18.87M 10-K · filed 2019-03-01 | |
| 2017-09-30 | $22.94M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $21.90M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $23.95M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $23.66M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $25.85M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $22.71M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $21.39M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $9.98M 10-K · filed 2017-03-01 | |
| 2015-09-30 | $3.79M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $2.96M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $3.02M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $3.22M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $4.15M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $5.00M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $5.75M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $6.28M 10-K · filed 2015-03-02 | |
| 2013-09-30 | $5.00M 10-Q · filed 2013-11-07 | |
| 2012-12-31 | $5.73M 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |